• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乌干达西南部一家教学医院诊断的威尔姆斯瘤病例的一年总体生存率及其预测因素:一项回顾性队列研究。

One year overall survival of wilms tumor cases and its predictors, among children diagnosed at a teaching hospital in South Western Uganda: a retrospective cohort study.

机构信息

Department of Surgery, Mbarara University of Science and Technology, Faculty of Medicine, Mbarara, Uganda.

Department of Anatomy, Faculty of Medicine Soroti University, Soroti, Uganda.

出版信息

BMC Cancer. 2023 Mar 2;23(1):196. doi: 10.1186/s12885-023-10601-2.

DOI:10.1186/s12885-023-10601-2
PMID:36864435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9979450/
Abstract

BACKGROUND

Wilms tumor (WT) is the second most common solid tumor in Africa with both low overall survival (OS) and event-free survival (EFS) rates. However, no known factors are predicting this poor overall survival.

OBJECTIVE

The study was to determine the one-year overall survival of WT cases and its predictors among children diagnosed in the pediatric oncology and surgical units of Mbarara regional referral hospital (MRRH), western Uganda.

METHODOLOGY

Children's treatment charts and files diagnosed and managed for WT were retrospectively followed up for the period between January 2017 to January 2021. Charts of children with histologically confirmed diagnoses were reviewed for demographics, clinical and histological characteristics, as well as treatment modalities.

RESULTS

One-year overall survival was found to be 59.3% (95% CI: 40.7-73.3), with tumor size greater than 15 cm (p 0.021) and unfavorable WT type (p 0.012) being the predominant predictors.

CONCLUSION

Overall survival (OS) of WT at MRRH was found to be 59.3%, and predictive factors noted were unfavorable histology and tumor size greater than 115 cm.

摘要

背景

威尔姆斯瘤(WT)是非洲第二大常见实体瘤,其总生存率(OS)和无事件生存率(EFS)均较低。然而,目前尚不清楚哪些因素可以预测这种较差的总体生存率。

目的

本研究旨在确定乌干达西部姆巴拉拉地区转诊医院(MRRH)儿科肿瘤学和外科病房诊断的 WT 病例的一年总体生存率及其预测因素。

方法

回顾性随访了 2017 年 1 月至 2021 年 1 月期间在 MRRH 接受治疗和管理的 WT 患儿的治疗图表和档案。对组织学确诊的患儿的图表进行了评估,以了解其人口统计学、临床和组织学特征以及治疗方式。

结果

发现一年总体生存率为 59.3%(95%CI:40.7-73.3),肿瘤大小大于 15cm(p<0.021)和不良 WT 类型(p<0.012)是主要的预测因素。

结论

MRRH 的 WT 总体生存率为 59.3%,不良组织学和肿瘤大小大于 115cm 是 noted 到的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/d95cc77a5495/12885_2023_10601_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/ff2494e50989/12885_2023_10601_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/4aa8cdb60556/12885_2023_10601_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/f2fe7f508afb/12885_2023_10601_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/a0c1591b7eed/12885_2023_10601_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/314c5b1421b3/12885_2023_10601_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/d95cc77a5495/12885_2023_10601_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/ff2494e50989/12885_2023_10601_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/4aa8cdb60556/12885_2023_10601_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/f2fe7f508afb/12885_2023_10601_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/a0c1591b7eed/12885_2023_10601_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/314c5b1421b3/12885_2023_10601_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/324f/9979450/d95cc77a5495/12885_2023_10601_Fig6_HTML.jpg

相似文献

1
One year overall survival of wilms tumor cases and its predictors, among children diagnosed at a teaching hospital in South Western Uganda: a retrospective cohort study.乌干达西南部一家教学医院诊断的威尔姆斯瘤病例的一年总体生存率及其预测因素:一项回顾性队列研究。
BMC Cancer. 2023 Mar 2;23(1):196. doi: 10.1186/s12885-023-10601-2.
2
Treatment abandonment in children with Wilms tumor at a national referral hospital in Uganda.乌干达国家转诊医院中儿童肾母细胞瘤的治疗中断情况。
Pediatr Surg Int. 2024 Jun 27;40(1):162. doi: 10.1007/s00383-024-05744-7.
3
The prognosis of prechemotherapy blastemal predominant histology subtype in Wilms tumor: A retrospective study in China.化疗前胚胎性为主的组织学分型对肾母细胞瘤预后的影响:中国的一项回顾性研究。
Pediatr Blood Cancer. 2020 Nov;67(11):e28567. doi: 10.1002/pbc.28567. Epub 2020 Aug 19.
4
Wilms tumor survival in Kenya.肯尼亚的威尔姆斯瘤存活率。
J Pediatr Surg. 2013 Jun;48(6):1254-62. doi: 10.1016/j.jpedsurg.2013.03.021.
5
Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.日本以母细胞瘤为主型的肾母细胞瘤:日本儿童癌症研究组
Pediatr Int. 2019 Apr;61(4):351-357. doi: 10.1111/ped.13811. Epub 2019 Apr 16.
6
Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience.小儿复发性肾母细胞瘤:中低收入国家的挑战——单中心经验。
J Egypt Natl Canc Inst. 2020 May 1;32(1):21. doi: 10.1186/s43046-020-00032-6.
7
MANAGEMENT AND OUTCOME OF PATIENTS WITH WILMS' TUMOUR (NEPHROBLASTOMA) AT THE MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.肯尼亚埃尔多雷特莫伊教学与转诊医院肾母细胞瘤(威尔姆斯瘤)患者的管理与治疗结果
East Afr Med J. 2012 Apr;89(4):121-7.
8
Outcomes of Wilms' tumor in eastern China: 10 years of experience at a single center.中国东部地区肾母细胞瘤的治疗结果:单中心10年经验
J Invest Surg. 2012 Jun;25(3):181-5. doi: 10.3109/08941939.2011.615893.
9
Bilateral Wilms tumors: Treatment results from a single center.双侧肾母细胞瘤:单中心治疗结果
Turk J Pediatr. 2019;61(1):44-51. doi: 10.24953/turkjped.2019.01.008.
10
Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999-2017).威尔姆斯瘤无事件生存和总体生存情况在南欧和东欧:四个儿童癌症登记处(1999-2017 年)的临床数据汇总分析。
Eur J Cancer. 2019 Jul;115:37-46. doi: 10.1016/j.ejca.2019.04.008. Epub 2019 May 10.

引用本文的文献

1
Hope and challenges in the diagnosis and treatment of Wilms tumor: a single-center retrospective study in China.肾母细胞瘤诊断与治疗中的希望与挑战:一项中国单中心回顾性研究
Front Pediatr. 2025 Apr 14;13:1527039. doi: 10.3389/fped.2025.1527039. eCollection 2025.
2
CT Image Parameters for Predicting Surgical Risk and Outcome in Wilms Tumor.用于预测肾母细胞瘤手术风险和预后的CT图像参数
Cureus. 2024 Nov 13;16(11):e73613. doi: 10.7759/cureus.73613. eCollection 2024 Nov.
3
The outcomes of children with primary malignant renal tumors: a 14-year single-center experience.

本文引用的文献

1
Outcomes of Wilms tumor treatment in western Kenya.肯尼亚西部肾母细胞瘤的治疗结果。
Pediatr Blood Cancer. 2022 Apr;69(4):e29503. doi: 10.1002/pbc.29503. Epub 2021 Dec 15.
2
Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2.Ⅰ期上皮优势型 Wilms 瘤的预后分析:来自儿童肿瘤协作组 AREN03B2 研究的报告。
Cancer. 2020 Jun 15;126(12):2866-2871. doi: 10.1002/cncr.32855. Epub 2020 Apr 8.
3
Global Disparities in Wilms Tumor.全球Wilms 瘤的差异。
儿童原发性肾脏恶性肿瘤的结局:14 年单中心经验。
BMC Cancer. 2024 Nov 12;24(1):1388. doi: 10.1186/s12885-024-13150-4.
4
Assessment of the Circulating PD-1 and PD-L1 Levels and P53 Expression as a Predictor of Relapse in Pediatric Patients with Wilms Tumor and Hypernephroma.评估循环中程序性死亡受体1(PD-1)和程序性死亡配体1(PD-L1)水平以及P53表达作为肾母细胞瘤和肾细胞癌小儿患者复发预测指标的研究
Children (Basel). 2024 Aug 23;11(9):1035. doi: 10.3390/children11091035.
5
Inter-Ethnic Variations in the Clinical, Pathological, and Molecular Characteristics of Wilms Tumor.肾母细胞瘤临床、病理及分子特征的种族间差异
Cancers (Basel). 2024 Sep 1;16(17):3051. doi: 10.3390/cancers16173051.
6
Survival characteristics of Wilms Tumor, a reference developed from a longitudinal cohort study.威尔姆斯瘤(肾母细胞瘤)的生存特征,来源于一项纵向队列研究的参考资料。
Ital J Pediatr. 2024 Aug 6;50(1):141. doi: 10.1186/s13052-024-01698-7.
7
Insights into Personalized Care Strategies for Wilms Tumor: A Narrative Literature Review.肾母细胞瘤个性化护理策略的见解:一篇叙述性文献综述
Biomedicines. 2024 Jun 30;12(7):1455. doi: 10.3390/biomedicines12071455.
8
Treatment abandonment in children with Wilms tumor at a national referral hospital in Uganda.乌干达国家转诊医院中儿童肾母细胞瘤的治疗中断情况。
Pediatr Surg Int. 2024 Jun 27;40(1):162. doi: 10.1007/s00383-024-05744-7.
9
High Expression of WT1 and Low Expression of p53 in Archived Blocks of Children with Wilms Tumor in South Western Uganda.乌干达西南部肾母细胞瘤患儿存档组织块中WT1高表达及p53低表达
Cancer Manag Res. 2024 Mar 6;16:127-136. doi: 10.2147/CMAR.S449982. eCollection 2024.
10
Performance of an offline systematic error correction strategy in pediatric patients receiving adjuvant conformal radiotherapy for Wilm's tumor.离线系统误差校正策略在接受辅助适形放疗的小儿 Wilms 肿瘤患者中的应用。
PLoS One. 2024 Feb 16;19(2):e0297997. doi: 10.1371/journal.pone.0297997. eCollection 2024.
J Surg Res. 2020 Mar;247:34-51. doi: 10.1016/j.jss.2019.10.044. Epub 2019 Dec 3.
4
Presentation and Outcomes of Childhood Cancer Patients at Uganda Cancer Institute.乌干达癌症研究所儿童癌症患者的临床表现与治疗结果
Glob Pediatr Health. 2019 May 18;6:2333794X19849749. doi: 10.1177/2333794X19849749. eCollection 2019.
5
Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.miR20a/106a-WTX 轴调节 RhoGDIa/CDC42 信号通路并促进结肠癌进展。
Nat Commun. 2019 Jan 10;10(1):112. doi: 10.1038/s41467-018-07998-x.
6
Treating Nephroblastoma in Rwanda: Using International Society of Pediatric Oncology Guidelines in a Novel Oncologic Care Model.在卢旺达治疗肾母细胞瘤:在新型肿瘤护理模式中采用国际小儿肿瘤学会指南
J Glob Oncol. 2016 Jan 27;2(3):105-113. doi: 10.1200/JGO.2015.000067. eCollection 2016 Jun.
7
The Evolving Role of Minimally Invasive Surgery in Pediatric and Adolescent Urologic Oncology.微创手术在儿童和青少年泌尿生殖系统肿瘤学中不断演变的作用。
Urology. 2016 May;91:180-9. doi: 10.1016/j.urology.2015.12.023.
8
Wilms' tumour: Determinants of prognosis in an African setting.肾母细胞瘤:非洲地区的预后决定因素。
Afr J Paediatr Surg. 2015 Jul-Sep;12(3):171-6. doi: 10.4103/0189-6725.170185.
9
Current surgical standards of care in Wilms tumor.肾母细胞瘤当前的外科护理标准。
Urol Oncol. 2016 Jan;34(1):13-23. doi: 10.1016/j.urolonc.2015.05.029. Epub 2015 Jun 26.
10
Innovations in the management of Wilms' tumor.威尔姆斯瘤治疗的创新。
Ther Adv Urol. 2014 Aug;6(4):165-76. doi: 10.1177/1756287214528023.